<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, June 27, 2018 (HealthDay News) There is no significant difference in abortion-related morbidities and adverse events following induced abortions, whether the procedure is performed in an ambulatory surgical center (ASC) or an office-based setting, according to a study published online June 26 in the Journal of the American Medical Association<\/i>.<\/p>\n
Sarah C. M. Roberts, Dr.P.H., from University of California, San Francisco, and colleagues retrospectively analyzed claims data from women with U.S. private health insurance who underwent induced abortions (n = 49,287) in an ASC or office-based setting (January 2011 through December 2014) in order to compare outcomes based on facility type.<\/p>\n
The researchers found that over the study period there were 50,311 induced
\nabortions (47 percent first-trimester aspiration, 27 percent first-trimester medication, and 26 percent second trimester or later). Eleven percent were performed in ASCs versus 89 in office-based settings. Overall, 3.33 percent had an abortion-related morbidity or adverse event, with 0.32 percent having a major abortion-related morbidity or adverse event. Abortion-related infection occurred in 0.74 percent. There was no statistically significant difference between ASCs and office-based settings, respectively, in the rates of abortion-related morbidities or adverse events (adjusted odds ratio [OR], 0.97; 95 percent confidence interval [CI], 0.81 to 1.17), major morbidities or adverse events (adjusted OR, 0.78; 95 percent CI, 0.45 to 1.37), or infections (adjusted OR, 0.75; 95 percent CI, 0.52 to 1.09) in adjusted analyses.<\/p>\n
“These findings, in addition to individual patient and individual facility factors, may inform decisions about the type of facility in which induced abortions are performed,” conclude the authors.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n